Evaluation of Intensive Adjuvant Chemotherapy in Gastric Cancer Using Life Expectancy Compared with Log-Rank Test as a Measure of Survival Benefit

By Nishikawa Toshikuni   Maetani Shunzo  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 348-354

Springer Publishing Company

Access to resources Recommend Favorite

CEA and CA19.9 as Early Predictors of Progression in Advanced/Metastatic Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy and Bevacizumab

By Petrioli Roberto   Licchetta Antonella   Roviello Giandomenico   Pascucci Alessandra   Francini Edoardo   Bargagli Gianluca   Conca Raffaele   Miano Salvatora Tindara   Marzocca Giuseppe   Francini Guido    

Cancer Investigation, Vol. 30, Iss. 1, 2012-01 ,pp. : 65-71

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy in the Treatment of Metastatic Gastric Cancer: Is There a Global Standard?

By Kang Hyunseok  

Current Treatment Options in Oncology, Vol. 12, Iss. 1, 2011-03 ,pp. : 96-106

Springer Publishing Company

Access to resources Recommend Favorite

Characterisation of tumour-infiltrating macrophages: impact on response and survival in patients receiving primary chemotherapy for breast cancer

By Heys Steven   Stewart Keith   McKenzie Emma   Miller Iain   Wong Simon   Sellar Grant   Rees Andrew  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 539-548

Springer Publishing Company

Access to resources Recommend Favorite

Predictive value of phosphorylated mammalian target of rapamycin for diseasefree survival in breast cancer patients receiving neoadjuvant chemotherapy

By  

Oncology Letters, Vol. 8, Iss. 6, 2014-01 ,pp. : 2642-2648

Spandidos Publications

Access to resources Recommend Favorite